印度尼西亚
越南
印度
菲律宾
土耳其
美国
墨西哥
加拿大
危地马拉
歌诗达黎加
阿根廷
巴西
智利
哥伦比亚
秘鲁
俄罗斯
乌克兰
法国
德国
意大利
埃塞俄比亚
乌干达
博茨瓦纳
加纳
肯尼亚
澳大利亚
新西兰
斐济
维尔京群岛
关岛
| 电子邮件 | - | 获取Email |
|---|
| 电子邮件 | - | 获取Email |
|---|
Zuellig Pharma is one of the largest healthcare services groups in Asia, and our mission is to make healthcare more accessible to the communities we serve. We provide world-class distribution, digital and commercial services to support the growing healthcare needs in this region. The company was started a hundred years ago and has grown to become a multi-billion dollar business covering 16 markets with over 12,000 employees. Our people serve more than 200,000 medical facilities and work with over 450 clients, including the top 20 pharmaceutical companies in the world.
| 公司 | Zuellig Pharma |
|---|---|
| 职位 | Regulatory Affairs Assistant Manager |
| 地点 | Malaysia |
| http://www.linkedin.com/in/arunachalam-subbiah-96219166 | |
| 部门 | |
| 头衔 | Regulatory Affairs Assistant Manager |
Zuellig Pharma Regulatory Affairs Assistant Manager
2022-02-01 -
Novo Nordisk Senior Regulatory professional
2021-04-01 - 2021-12-01
Novo Nordisk Regulatory Affairs and Pharmacovigilance Associate
2019-04-01 - 2021-03-01
Senior Executive Business Development
2018-05-01 - 2018-12-01
Senior Regulatory Affairs & Business Development Executive
2017-12-01 - 2018-04-01
Arunachalam Subbiah 在 Zuellig Pharma 担任 Regulatory Affairs Assistant Manager
Arunachalam Subbiah 在 Zuellig Pharma 的职位是 Regulatory Affairs Assistant Manager
Arunachalam Subbiah 的电子邮件地址是 -
Arunachalam Subbiah 的电话号码是 -
Arunachalam Subbiah 的公司电话号码是 +656****
Arunachalam Subbiah 在 pharmaceuticals 工作。
Arunachalam Subbiah 的一些同事包括Noche Joy、Aik Tey、Omar Chiong、Nikkolo LadaoArnold Rowan、。
Arunachalam Subbiah联系方式： 电子邮件地址：- 电话号码：-
Arunachalam Subbiah 的个人领英是：http://www.linkedin.com/in/arunachalam-subbiah-96219166
Arunachalam Subbiah 的办公地点：47 Scotts Road, Goldbell Towers, #10-00, Singapore, Singapore 228233, SG
Top-ranked on G2 Crowd
全球B2B企业库 海关贸易数据 展会采购数据
全球B2B企业库
海关贸易数据
展销采购数据
Top-ranked on G2 Crowd
Sign Up with Google
